I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Randomized controlled phase II trial to test the safety and preliminary efficacy of a dual thrombolytic treatment consisting of a small intravenous (IV) bolus of alteplase followed by IV infusion of mutant pro-urokinase against usual treatment with IV alteplase in patients presenting with ischemic stroke.
iv infusion
tissue plasminogen activator
plasminogen activator
thrombolytic drugs
alteplase
- 0 views
- 16 Feb, 2024
- 1 location